DISCOSOMES: A FUTURISTIC UPHEAVAL IN VESICULAR DRUG DELIVERY

Authors

  • AMITHA MARY JOSE Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Aims Health Sciences Campus, Kochi 682041, Kerala, India
  • V. U. LAKSHMI Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Aims Health Sciences Campus, Kochi 682041, Kerala, India
  • GAYATHRI S. Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Aims Health Sciences Campus, Kochi 682041, Kerala, India
  • SREEJA C. NAIR Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Aims Health Sciences Campus, Kochi 682041, Kerala, India

DOI:

https://doi.org/10.22159/ijap.2021v13i6.42008

Keywords:

Discosomes, Novel drug delivery, Disc-shaped, Giant niosomes, Non-ionic surfactant, Ophthalmic, Cul-de-sac

Abstract

The formulation system employed to convey pharmaceutical drugs compound in the body to attain the desired therapeutic effect at a predetermined rate depending on pharmacological aspects, drug profile, and physiological conditions can be referred to as a novel drug delivery system (NDDS). Due to the intricately sensitive anatomy and physiology of the eye pharmacologist find the ocular delivery system to be more involuted than other routes. Pre-corneal, static and dynamic is the 3 types of ophthalmic barriers, which along with the inflow and outflow of lacrimal fluids, nasolacrimal drainage are some of the germane factors that affect bioavailability. Unlike conventional dosage forms, where the distribution of drugs in non-targeted body fluids and tissues, transcends the quantity of required drug in targeted tissues and causes repercussions, these modified drug delivery systems surpass the ocular barriers and adverse reactions, emphasizing on less invasive, prolonged action. It also promotes sustained release formulation that subjugates the drug loss or degradation, to treat many ocular diseases effectively. The current review recapitulates the fundamentals of discosomes, a type of vesicular drug delivery system that acts as a vehicle for the drug delivery of both hydrophilic and lipophilic drugs. Discosomes are giant, disc-shaped structures modified from niosomes by arresting the vesicles at the discosome phase. Due to their idiosyncratic size, it provides all due benefits compared to other ocular drug delivery systems. From the review, it can be culminated that discosomes are a potential subject of opposition and opportunities in the arena of safe and effective ocular drug delivery.

Downloads

Download data is not yet available.

References

Aslam Abdul Rahiman CA, Krishnan K, Sreelekshmi AS, Arjun KK, Nair SC.Novasome: A pioneering advancement in vesicular drug delivery. Int J App Pharm 2021; 13: 59-64.

Kamboj S, Saini V, Maggon N, Bala S, Jhawat V.Vesicular drug delivery systems: a novel approach for drug targeting. Int J Drug Deliv 2013; 5:121-30.

Ravalika V, & Sailaja A. Formulation and evaluation of etoricoxib niosomes by thin film hydration technique and ether injection method. Nano Biomed Eng 2017; 9: 242-248.

Manish G, Vimukta S.Targeted drug delivery system: a review. Res J Chem Sci 2011; 1:135-8.

Mujoriya R, Bodla RB, Dhamande K, Singh D, Patle L.Niosomal drug delivery system: The magic bullet. J Appl Pharm Sci 2011; 1:20-3.

Naseri N, Valizadeh H, & Zakeri-Milani P. Solid lipid nanoparticles and nanostructured lipid carriers: structure, preparation and application. Adv Pharm Bull 2015; 5:305.

Pandita A, Sharma P. Pharmacosomes: an emerging novel vesicular drug delivery system for poorly soluble synthetic and herbal drugs. Int Sch Res Notices 2013; 4:1-9.

Suttee A, Mishra V, Nayak P, Singh M, & Sriram P. Niosomes: Potential Nanocarriers for Drug Delivery. Int J Pharm Clin Res 2020; 11: 389-394.

Baranowski P, Karolewicz B, Gajda M, Pluta J. Ophthalmic drug dosage forms: characterization and research methods. Sci World J 2014:1-15.

Pillai DV, Sabitha M, Swati P Gupta. Brinzolamide-2-hydroxypropyl beta cyclodextrin complex loaded chitosan nanogel for ocular drug delivery. Int J Pharm Res 2019; 11:350-62.

Keerthana R, Gayathri P.S, Krishnakumar G and Nair SC. Vesosomes: New Prospects in Multi Compartment Vesicular Drug Delivery System. Int J Pharm Res 2020; 12: 869-77.

Chaudhari S P, & Gaikwad S U. Sphingosomes: A Novel Lipoidal Vesicular Drug Delivery System. J Sci Tech 2020;5(4):2456-5660.

Kazi K M, Mandal A S, Biswas N, Guha A, Chatterjee S, Behera M, et al. Niosome: a future of targeted drug delivery systems. J Adv Pharm Tech Res 2010; 1: 374.

Verma A, Tiwari A, Saraf S, Panda PK, Jain A, Jain S. Emerging potential of niosomes in ocular delivery. Expert Opin Drug Deliv 2020; 18:55-71.

Jaimini G, Pranav S. A Review on Current Perspectives and Recent Advances in Ocular Drug Delivery System. Int J Chemtech Res 2018; 11: 314-326.

Gorantla S, Rapalli VK, Waghule T, Singh PP, Dubey SK, Saha RN, et al. Nanocarriers for ocular drug delivery: current status and translational opportunity. RSC Advances 2020;10: 27835-27855.

Shaikh R, Singh TR, Garland MJ, Woolfson AD, Donnelly RF. Mucoadhesive drug delivery systems. J Pharm Bioallied Sci 2011; 3: 89-100.

Marion Dubald, Sandrine Bourgeois, Véronique Andrieu, Hatem Fessi. Ophthalmic Drug Delivery Systems for Antibiotherapy—A Review. Pharmaceutics 2018:10.

Mahale NB, Thakkar PD, Mali RG, Walunj DR, Chaudhari SR. Niosomes: novel sustained release nonionic stable vesicular systems—an overview. Adv Colloid Interface sci 2012; 183:46-54.

Mistry R, Patel R. Drug design concept in ocular drug delivery. PharmaTutor 2014; 2: 49-61.

Yun YH, Lee BK, Park K. Controlled Drug Delivery: Historical perspective for the next generation.J Control Release 2015;219:2-7.

Gaudana R, Ananthula HK, Parenky A, Mitra AK. Ocular drug delivery, AAPS J 2010; 12: 348-60.

Lavik E, Kuehn MH, Kwon YH. Novel drug delivery systems for glaucoma.Eye 2011; 25: 578-86.

Satis Shilpi, Devendra Choudhary, Gaurav K.Sarogi,Dhanashree Chordiya,Dyaneshwar Kalyane,Rakesh Tekade. Chapter 17-Proliposomes: a potential colliodal carrier for drug delivery applications. Rakesh T, editor. The future pharmaceutical product development and research. 1st ed United States: Academic press; 2020. p.581-608.

Yu X, Trase I, Ren M, Duval K, Guo X, Chen Z. Design of Nanoparticle-Based Carriers for Targeted Drug Delivery. J Nanomater 2016;2016:1087250.

Achouri D, Alhanout K, Piccerelle P, Andrieu V. Recent advances in ocular drug delivery. Drug Dev Ind Pharm. 2013 ; 39 :1599-617.

Abdelkader H, Ismail S, Kamal A, Alany R. Design and evaluation of controlled-release niosomes and discomes for naltrexone hydrochloride ocular delivery. J Pharm Sci 2011; 100: 1833-1846.

Chang HI, Yeh MK. Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy. Int J nanomedicine 2012; 7:49-60.

Evelyn Addo, Oluyemisi A. Bamiro , Rodney Siwale.Chapter 2-Anatomy of eye and common diseases affecting the eye.Richard T, Addo, editors. Ocular drug delivery: advances, challenges and applications. USA: Springer; 2016. p.11-25.

Durak S, Esmaeili Rad M, Alp Yetisgin A, Eda Sutova H, Kutlu O, Cetinel S, et al. Niosomal drug delivery systems for ocular disease—recent advances and future prospects. Nanomater 2020; 10: 1191.

Bincy WS, Arun JL. A review on niosomes in ocular drug delivery system. Int J Res 2020; 7:484-91.

Archana Pandita, Pooja Sharma.Pharmacosomes: an emerging vesicular system for poorly soluble synthetic and herbal drugs. Int Sch Res Notices 2013; 2013.

Ioele G, De Luca M, Garofalo A, Ragno G. Photosensitive drugs: a review on their photoprotection by liposomes and cyclodextrins. Drug Deliv 2017; 24: 33-44.

Kaur D, Kumar S. Niosomes: present scenario and future aspects. J Drug Deliv Ther 2018; 8:35-43.

Sahoo RK, Biswas N, Guha A, Sahoo N, Kuotsu K. Nonionic surfactant vesicles in ocular delivery: innovative approaches and perspectives. Biomed Res Int 2014: 2-9.

Gandhi A, Sen SO, Paul A, Current trends in niosome as vesicular drug delivery system, Asian J Pharm life Sci 2012;2:339-53.

Ag Seleci D, Seleci M, Walter JG, Stahl F, Scheper T. Niosomes as nanoparticular drug carriers: fundamentals and recent applications. J nanomater 2016:1-9

Diljyot K. Niosomes: a new approach to targeted drug delivery. Int J Pharm Phytopharm Res 2012; 2: 53-9.

Kumar GP, Rajeshwarrao P. Nonionic surfactant vesicular systems for effective drug delivery—an overview. Acta Pharmaceutica Sinica B 2011; 1: 208-19.

Yeo PL, Lim CL, Chye SM, Ling AP, Koh RY. Niosomes: a review of their structure, properties, methods of preparation, and medical applications. Asian Biomed 2018; 11: 301-14.

Leitgeb Maja, Knez Željko, Primožič Mateja. Sustainable technologies for liposome preparation.J Supercrit Fluids 2020;165:104984.

Rita Muzzalupo, Elisabetta Mazzotta. Do niosomes have a place in the field of drug delivery?. Expert Opin Drug Deliv 2019; 16:45-1147.

Yeo P, Lim C, Chye S, Kiong Ling A, Koh R. Niosomes: a review of their structure, properties, methods of preparation, and medical applications. Asian Biomed 2018;11:301-14.

Kwatra D, Mitra AK. Drug delivery in ocular diseases: Barriers and strategies. World J Pharmacol 2013; 2: 78-83.

Surbhi Dubey, Rajeev Sharma, Nishi Mody, Suresh P. Vyas.Chapter 24 - Novel carriers and approaches: insight for psoriasis management,Editors: Denisa Ficai, Alexandru Mihai Grumezescu.In Micro and Nano Technologies,Nanostructures for Novel Therapy.1st ed United States of America: Elsevier ;2017.p.657-684.

Durga Bhavani.G, Veeralakshmi.P. Recent advances of non-ionic surfactant-based nano-vesicles (niosomes and proniosomes): a brief review of these in enhancing transdermal delivery of drug. Futur J Pharm Sci 2020;6.

Biswas GR, & Majee SB. Niosomes in ocular drug delivery. Eur J Pharm Med Res 2017; 4: 813-819.

Gharbavi M, Amani J, Kheiri-Manjili H, Danafar H, Sharafi A. Niosome: a promising nanocarrier for natural drug delivery through blood-brain barrier. Adv Pharm Sci 2018.

Durak S, Esmaeili Rad M, Alp Yetisgin A, et al. Niosomal Drug Delivery Systems for Ocular Disease—Recent Advances and Future Prospects. Nanomater 2020; 10: 1191.

Patel A, Cholkar K, Agrahari V, Mitra AK. Ocular drug delivery systems: An overview. World J Pharmacol 2013; 2:47-64.

Abdelkader H, Alani AW, Alany RG. Recent advances in non-ionic surfactant vesicles (niosomes): self-assembly, fabrication, characterization, drug delivery applications and limitations. Drug Deliv 2014; 21: 87-100.

Bhardwaj P, Tripathi P, Gupta R, Pandey S. Niosomes: A review on niosomal research in the last decade. J Drug Deliv Sci Tech 2020; 56: 101581.

Raj VK, Mazumder R, and Madhra M. Ocular drug delivery system: Challenges and approaches. Int J Appl Pharm 2020; 12: 49-57.

Ameeduzzafar, Alruwaili, N.K., Imam, S.S. et al. Formulation of Chitosan Polymeric Vesicles of Ciprofloxacin for Ocular Delivery: Box-Behnken Optimization, In Vitro Characterization, HET-CAM Irritation, and Antimicrobial Assessment. AAPS PharmSciTech 2020;21(167).

Abdelkader H, Ismail S, Hussein A, Wu Z, Al-Kassas R, Alany RG. Conjunctival and corneal tolerability assessment of ocular naltrexone niosomes and their ingredients on the hen's egg chorioallantoic membrane and excised bovine cornea models. Int J Pharm. 2012 ;432:1-10.

Jafariazar Z, Jamalinia N, Ghorbani-Bidkorbeh F, Mortazavi SA. Design and Evaluation of ocular Controlled Delivery System for Diclofenac Sodium. Iran J Pharm Res 2015; 14:23-31.

Kazi KM, Mandal AS, Biswas N, Guha A, Chatterjee S, Behera M, et al. Niosome: A future of targeted drug delivery systems. J Adv Pharm Technol Res 2010; 1:374-80.

Abdelkader H, Wu Z, Al-Kassas R, Alany RG. Niosomes and discomes for ocular delivery of naltrexone hydrochloride: morphological, rheological, spreading properties and photo-protective effects. Int J Pharm 2012; 433: 142-48.

Gannu P Kumar, Pogaku Rajeshwarrao. Non-ionic surfactant vesicular sysem for effective drug delivery - an overview. Acta Pharmaceutica Silica B 2011; 1: 208-19.

Tangri P, Khurana S. Niosomes: formulation and evaluation. Int J Biopharm 2011; 2229:7499.

Sharma R, Dua JS, Prasad DN, Hira S. Advancement in novel drug delivery system: niosomes. J Drug Deliv Ther2019; 9: 995-1001.

Singh D, Upadhyay P. Niosomes: A Novel Vescular Approach. World J Pharm Pharm Sci 2016; 5 :1586-92.

Kumari A, Sharma PK, Garg VK, Garg G. Ocular inserts—Advancement in therapy of eye diseases. J Adv Pharm Techol Res 2010; 1: 291.

Mobaraki M, Soltani M, Zare Harofte S, L Zoudani E, Daliri R, Aghamirsalim M, et al. Biodegradable Nanoparticle for Cornea Drug Delivery: Focus Review. Pharmaceutics 2020; 12: 1232.

Homaei M. Preparation and characterization of giant niosomes. Master's thesis in nanotechnology. Chalmer’s university of technology. Sweden; 2016:1-19.

Tsai C H, Wang PY, Lin I, Huang H, Liu GS, Tseng CL. Ocular drug delivery: Role of degradable polymeric nanocarriers for ophthalmic application. Int J Mol Sci 2018; 19:2830.

Kamalasanan K. Drug Delivery in New Decade of 2020 Onwards: Considerations for Designing Diffusion Based Drug Delivery Devices. Trends Biomater Artif Organs 2020;34:73-4.

Inoue Y, Shimura A, Horage M, Maeda R, Murata I, Sugino M, et al. Effects of the properties of creams on skin penetration. Int J Pharm 2015; 5: 645-54.

Patel A, Cholkar K, Agrahari V, Mitra AK. Ocular drug delivery systems: an overview. World J Pharmacol 2013; 2: 47.

Zakir F, Manvi S. and Zeenat I. Ocular drug delivery: Recent updates. Int J Drug Regul Aff 2016; 4: 15-22.

Durak S, Esmaeili Rad M, Alp Yetisgin A, Eda Sutova H, Kutlu O, Cetinel S, et al. Niosomal drug delivery systems for ocular disease—recent advances and future prospects. Nanomater 2020;10 :1191.

FIGURE REFERENCES

Yeo P, Lim C, Chye S, Kiong Ling A, Koh R. Niosomes: a review of their structure, properties, methods of preparation, and medical applications. Asian Biomed 2018;11:301-14.

Kwatra D, Mitra AK. Drug delivery in ocular diseases: Barriers and strategies. World J Pharmacol 2013; 2: 78-83.

Surbhi Dubey, Rajeev Sharma, Nishi Mody, Suresh P. Vyas.Chapter 24 - Novel carriers and approaches: insight for psoriasis management,Editors: Denisa Ficai, Alexandru Mihai Grumezescu.In Micro and Nano Technologies,Nanostructures for Novel Therapy.1st ed United States of America: Elsevier ;2017.p.657-684.

Durga Bhavani.G, Veeralakshmi.P. Recent advances of non-ionic surfactant-based nano-vesicles (niosomes and proniosomes): a brief review of these in enhancing transdermal delivery of drug. Futur J Pharm Sci 2020;6.

Biswas GR, & Majee SB. Niosomes in ocular drug delivery. Eur J Pharm Med Res 2017; 4: 813-819.

Abdelkader H, Alani AW, Alany RG. Recent advances in non-ionic surfactant vesicles (niosomes): self-assembly, fabrication, characterization, drug delivery applications and limitations. Drug Deliv 2014; 21: 87-100.

Published

21-09-2021

How to Cite

MARY JOSE, A., LAKSHMI, V. U., S., G., & C. NAIR, S. (2021). DISCOSOMES: A FUTURISTIC UPHEAVAL IN VESICULAR DRUG DELIVERY. International Journal of Applied Pharmaceutics, 13(6). https://doi.org/10.22159/ijap.2021v13i6.42008

Issue

Section

Review Article(s)

Most read articles by the same author(s)